The former head of a U.S. biotech firm is facing jail time for securities fraud by misleading investors about the prospects for a...
CN Editor
January 27, 2026
OSC"S DISCLOSURE ISSUES DIDN"T JUSTIFY STAY: TRIBUNAL
AS U.K. GEARS UP FOR T+1, INDUSTRY BUDGETS LAG
TRIBUNAL BANS TRADER, AFTER THE FIRST BAN DIDN"T TAKE
COURT HOLDS LAWYER ACCOUNTABLE FOR AI HALLUCINATIONS
Thank you for the feedback!!
2026 COMPLIANCE PRIORITIES AND REGULATORY DIVISION INITIATIVES
THE BANKER, THE BROTHERS, THE FRIENDS AND THEIR FRAUDS
DRAMATIC INCREASE IN FINTRAC FINES COMING, BUT THEIR EFFECTIVENESS IS LESS CLEAR
CIRO SANCTIONS FORMER RBC DOMINION SECURITIES REP FROM ONTARIO